VRS
AKBA icon

Virginia Retirement Systems’s Akebia Therapeutics AKBA Stock Holding History

Virginia Retirement Systems’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-85,000
Closed -$137K – 935
2025
Q4 		$137K Buy
+85,000
New +$178K ﹤0.01% 931
2022
Q1 		– Sell
-111,800
Closed -$253K – 1111
2021
Q4 		$253K Sell
111,800
-47,000
-30% -$128K ﹤0.01% 1010
2021
Q3 		$457K Buy
158,800
+102,400
+182% +$292K ﹤0.01% 806
2021
Q2 		$214K Buy
56,400
+9,600
+21% +$32.3K ﹤0.01% 982
2021
Q1 		$158K Buy
46,800
+26,400
+129% +$95.1K ﹤0.01% 1080
2020
Q4 		$57K Sell
20,400
-86,100
-81% -$251K ﹤0.01% 1093
2020
Q3 		$267K Sell
106,500
-5,300
-5% -$46.5K ﹤0.01% 959
2020
Q2 		$1.52M Sell
111,800
-40,900
-27% -$423K 0.02% 453
2020
Q1 		$1.16M Buy
152,700
+137,900
+932% +$1.07M 0.02% 496
2019
Q4 		$94K Sell
14,800
-7,700
-34% -$36.6K ﹤0.01% 1116
2019
Q3 		$88K Buy
+22,500
New +$96.4K ﹤0.01% 1095
2019
Q2 		– Sell
-16,200
Closed -$133K – 1115
2019
Q1 		$133K Buy
16,200
+2,500
+18% +$17.2K ﹤0.01% 1048
2018
Q4 		$76K Buy
+13,700
New +$107K ﹤0.01% 1044
2018
Q3 		– Sell
-141,100
Closed -$1.41M – 1028
2018
Q2 		$1.41M Buy
141,100
+102,600
+266% +$1.03M 0.02% 560
2018
Q1 		$367K Buy
+38,500
New +$539K ﹤0.01% 873

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Virginia Retirement Systems's AKBA Position: Q1 2026 in Review

Virginia Retirement Systems sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 85,000 shares — an estimated $137K sold.

Virginia Retirement Systems first reported a position in AKBA in Q1 2018 and held it in 15 quarters. The position peaked at $1.52M in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Virginia Retirement Systems reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 85,000 Akebia Therapeutics shares in Q1 2026, an estimated $137K.
  • Virginia Retirement Systems first reported a position in Akebia Therapeutics in Q1 2018 and held it in 15 quarters.
  • Virginia Retirement Systems's Akebia Therapeutics position peaked at $1.52M in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Virginia Retirement Systems's 13F filing for Q1 2026, filed 25 Aug 2026.